CRT 2023
Ongoing Coronary Trials at the European Cardiovascular Research Institute (Non-CME) - Sponsored by Cardialysis
Robert Diletti, MD
Disclosure information not submitted.
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC
Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands
Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)